Filing metadata

Accession number
0000899243-20-011293
Form type
Form 3
Filer
Aimmune Therapeutics, Inc.
CIK
CIK 1631650
Filed
Apr 24, 2020
Reporting period
Dec 31, 2018
Description
Initial ownership

Explore SEC Filings Hub